Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Phosphorylation of the adaptor ASC acts as a molecular switch that controls the formation of speck-like aggregates and inflammasome activity

Abstract

The inflammasome adaptor ASC contributes to innate immunity through the activation of caspase-1. Here we found that signaling pathways dependent on the kinases Syk and Jnk were required for the activation of caspase-1 via the ASC-dependent inflammasomes NLRP3 and AIM2. Inhibition of Syk or Jnk abolished the formation of ASC specks without affecting the interaction of ASC with NLRP3. ASC was phosphorylated during inflammasome activation in a Syk- and Jnk-dependent manner, which suggested that Syk and Jnk are upstream of ASC phosphorylation. Moreover, phosphorylation of Tyr144 in mouse ASC was critical for speck formation and caspase-1 activation. Our results suggest that phosphorylation of ASC controls inflammasome activity through the formation of ASC specks.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Syk and Jnk are required for IL-18 secretion mediated by NLRP3 and AIM2 but not that mediated by NLRC4.
Figure 2: Involvement of Syk and Jnk in NLRP3- and AIM2-mediated activation of caspase-1.
Figure 3: Requirement for signaling via Syk and Jnk for ASC aggregation.
Figure 4: Phosphorylation of ASC in macrophages after activation of the inflammasome.
Figure 5: Identification of amino acid residues in ASC critical for its biological activities.
Figure 6: Critical roles of the possible phosphorylation sites of ASC in macrophages.
Figure 7: Identification of phosphorylation sites in ASC.
Figure 8: Involvement of Syk and Jnk in inflammatory responses to MSU in vivo.

Similar content being viewed by others

References

  1. Martinon, F., Mayor, A. & Tschopp, J. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27, 229–265 (2009).

    Article  CAS  PubMed  Google Scholar 

  2. Brodsky, I.E. & Monack, D. NLR-mediated control of inflammasome assembly in the host response against bacterial pathogens. Semin. Immunol. 21, 199–207 (2009).

    Article  CAS  PubMed  Google Scholar 

  3. Davis, B.K., Wen, H. & Ting, J.P. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu. Rev. Immunol. 29, 707–735 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Dinarello, C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27, 519–550 (2009).

    Article  CAS  PubMed  Google Scholar 

  5. Miao, E.A. et al. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc. Natl. Acad. Sci. USA 107, 3076–3080 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Franchi, L. et al. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1β in salmonella-infected macrophages. Nat. Immunol. 7, 576–582 (2006).

    Article  CAS  PubMed  Google Scholar 

  7. Miao, E.A. et al. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat. Immunol. 7, 569–575 (2006).

    Article  CAS  PubMed  Google Scholar 

  8. Boyden, E.D. & Dietrich, W.F. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat. Genet. 38, 240–244 (2006).

    Article  CAS  PubMed  Google Scholar 

  9. Franchi, L., Munoz-Planillo, R., Reimer, T., Eigenbrod, T. & Nunez, G. Inflammasomes as microbial sensors. Eur. J. Immunol. 40, 611–615 (2010).

    Article  CAS  PubMed  Google Scholar 

  10. Mariathasan, S. et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228–232 (2006).

    Article  CAS  PubMed  Google Scholar 

  11. Kanneganti, T.D. et al. Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J. Biol. Chem. 281, 36560–36568 (2006).

    Article  CAS  PubMed  Google Scholar 

  12. Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237–241 (2006).

    Article  CAS  PubMed  Google Scholar 

  13. Li, H., Nookala, S. & Re, F. Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1beta and IL-18 release. J. Immunol. 178, 5271–5276 (2007).

    Article  CAS  PubMed  Google Scholar 

  14. Rathinam, V.A. et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat. Immunol. 11, 395–402 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Fernandes-Alnemri, T. et al. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat. Immunol. 11, 385–393 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Tsuchiya, K. et al. Involvement of absent in melanoma 2 in inflammasome activation in macrophages infected with Listeria monocytogenes. J. Immunol. 185, 1186–1195 (2010).

    Article  CAS  PubMed  Google Scholar 

  17. Kim, S. et al. Listeria monocytogenes is sensed by the NLRP3 and AIM2 inflammasome. Eur. J. Immunol. 40, 1545–1551 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Fang, R. et al. Critical roles of ASC inflammasomes in caspase-1 activation and host innate resistance to Streptococcus pneumoniae infection. J. Immunol. 187, 4890–4899 (2011).

    Article  CAS  PubMed  Google Scholar 

  19. Kerur, N. et al. IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi sarcoma-associated herpesvirus infection. Cell Host Microbe 9, 363–375 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Masumoto, J. et al. ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells. J. Biol. Chem. 274, 33835–33838 (1999).

    Article  CAS  PubMed  Google Scholar 

  21. Case, C.L., Shin, S. & Roy, C.R. Asc and Ipaf Inflammasomes direct distinct pathways for caspase-1 activation in response to Legionella pneumophila. Infect. Immun. 77, 1981–1991 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Bryan, N.B., Dorfleutner, A., Rojanasakul, Y. & Stehlik, C. Activation of inflammasomes requires intracellular redistribution of the apoptotic speck-like protein containing a caspase recruitment domain. J. Immunol. 182, 3173–3182 (2009).

    Article  CAS  PubMed  Google Scholar 

  23. Fernandes-Alnemri, T. et al. The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ. 14, 1590–1604 (2007).

    Article  CAS  PubMed  Google Scholar 

  24. Guarda, G. et al. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 34, 213–223 (2011).

    Article  CAS  PubMed  Google Scholar 

  25. Mayor, A., Martinon, F., De Smedt, T., Petrilli, V. & Tschopp, J. A crucial function of SGT1 and HSP90 in inflammasome activity links mammalian and plant innate immune responses. Nat. Immunol. 8, 497–503 (2007).

    Article  CAS  PubMed  Google Scholar 

  26. Franchi, L. et al. Calcium-independent phospholipase A2β is dispensable in inflammasome activation and its inhibition by bromoenol lactone. J. Innate Immun. 1, 607–617 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Qu, Y. et al. Phosphorylation of NLRC4 is critical for inflammasome activation. Nature 490, 539–542 (2012).

    Article  CAS  PubMed  Google Scholar 

  28. Gross, O. et al. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 459, 433–436 (2009).

    Article  CAS  PubMed  Google Scholar 

  29. Shio, M.T. et al. Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases. PLoS Pathog. 5, e1000559 (2009).

    Article  CAS  PubMed  Google Scholar 

  30. Chuang, Y.T. et al. Tumor suppressor death-associated protein kinase is required for full IL-1β production. Blood 117, 960–970 (2011).

    Article  CAS  PubMed  Google Scholar 

  31. Kankkunen, P. et al. (1,3)-beta-glucans activate both dectin-1 and NLRP3 inflammasome in human macrophages. J. Immunol. 184, 6335–6342 (2010).

    Article  CAS  PubMed  Google Scholar 

  32. Lu, B. et al. Novel role of PKR in inflammasome activation and HMGB1 release. Nature 488, 670–674 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Wong, K.W. & Jacobs, W.R. Jr. Critical role for NLRP3 in necrotic death triggered by Mycobacterium tuberculosis. Cell Microbiol. 13, 1371–1384 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Stehlik, C. et al. The PAAD/PYRIN-only protein POP1/ASC2 is a modulator of ASC-mediated nuclear-factor-κB and pro-caspase-1 regulation. Biochem. J. 373, 101–113 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Kosako, H. et al. Phosphoproteomics reveals new ERK MAP kinase targets and links ERK to nucleoporin-mediated nuclear transport. Nat. Struct. Mol. Biol. 16, 1026–1035 (2009).

    Article  CAS  PubMed  Google Scholar 

  36. Kurokawa, M. & Kornbluth, S. Caspases and kinases in a death grip. Cell 138, 838–854 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Sumbayev, V.V. & Yasinska, I.M. Role of MAP kinase-dependent apoptotic pathway in innate immune responses and viral infection. Scand. J. Immunol. 63, 391–400 (2006).

    Article  CAS  PubMed  Google Scholar 

  38. Balci-Peynircioglu, B. et al. Expression of ASC in renal tissues of familial mediterranean fever patients with amyloidosis: postulating a role for ASC in AA type amyloid deposition. Exp. Biol. Med. (Maywood) 233, 1324–1333 (2008).

    Article  CAS  Google Scholar 

  39. Villani, A.C. et al. Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nat. Genet. 41, 71–76 (2009).

    Article  CAS  PubMed  Google Scholar 

  40. Zaki, M.H. et al. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32, 379–391 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Jin, Y. et al. NALP1 in vitiligo-associated multiple autoimmune disease. N. Engl. J. Med. 356, 1216–1225 (2007).

    Article  CAS  PubMed  Google Scholar 

  42. Vandanmagsar, B. et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17, 179–188 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Duewell, P. et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357–1361 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Pope, R.M. & Tschopp, J. The role of interleukin-1 and the inflammasome in gout: implications for therapy. Arthritis Rheum. 56, 3183–3188 (2007).

    Article  CAS  PubMed  Google Scholar 

  45. Hara, H. et al. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nat. Immunol. 8, 619–629 (2007).

    Article  CAS  PubMed  Google Scholar 

  46. Cao, Y. et al. Enhanced T cell-independent antibody responses in c-Jun N-terminal kinase 2 (JNK2)-deficient B cells following stimulation with CpG-1826 and anti-IgM. Immunol. Lett. 132, 38–44 (2010).

    Article  CAS  PubMed  Google Scholar 

  47. Turner, M. et al. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 378, 298–302 (1995).

    Article  CAS  PubMed  Google Scholar 

  48. Hara, H. et al. Dependency of caspase-1 activation induced in macrophages by Listeria monocytogenes on cytolysin, listeriolysin O, after evasion from phagosome into the cytoplasm. J. Immunol. 180, 7859–7868 (2008).

    Article  CAS  PubMed  Google Scholar 

  49. Lutz, M.B. et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223, 77–92 (1999).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank J. Tschopp and the Institute for Arthritis Research for permission to use Nlrp3−/− mice; S.Taniguchi (Shinshu University) for Pycard−/− mice; K. Kuida (Millennium Pharmaceuticals) for Casp1−/− mice; T. Saito (RIKEN RCAI) for Card9−/− mice; K. Kawasaki (Doshisha Women's College) for S. Typhimurium 14028; H. Tsutsui (Hyogo Medical University) for Nlrp3−/−, Pycard−/− and Casp1−/− mice; H. Hara (Saga University) for Card9−/− mice; M. Matsuura (Kyoto University) for S. Typhimurium 14028 and for U937 cells; H. Tanizaki (Kyoto University) for RAW264.7 cells; and K. Sada and Y. Tohyama for advice on Syk experiments. Supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Ministry of Health, Labour and Welfare of Japan, the Japan Society for the Promotion of Science and Medical Research Council UK (U117527252 for E.S. and V.T.).

Author information

Authors and Affiliations

Authors

Contributions

H.H. initiated the study and designed and did the experiments with macrophages and peritonitis; K.T. designed and did the experiments with HEK293 cells; K.T., H.H. and M.M. wrote the manuscript; I.K. provided advice; R.F., E.H.-C. and Y.S. contributed to the experiments; J.M. provided the Mapk8−/− and Mapk9−/− mice; E.S. and V.T. provided the Syk+/+, Syk+/− and Syk−/− fetal liver cells; and M.M. supervised the project.

Corresponding author

Correspondence to Masao Mitsuyama.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Integrated supplementary information

Supplementary Figure 1 Inhibition of Syk or Jnk do not affect the expression of inflammasome molecules.

(a,d,f) Immunoblot analysis of inflammasome molecules or (b,c,e) Enzyme-linked immunosorbent assayof IL-18 in peritoneal macrophages (a,d–f), bone marrow–derived macrophages(b), or U937 cells (c) primed with LPS for 4 h (a), followed by stimulation with nigericin for 90 min (b–d), or alum for 6 h (e,f). The indicated kinase inhibitors were added to the cultures 1 h before stimulation. CL, cell lysates; SN, supernatants. Data are shown as the means ± s.d. of triplicate samples of one experiment representative of three independent experiments. Data were analyzed by one-way ANOVA with Bonferroni multiple comparison test (b,c,e). * P < 0.01 and ** P < 0.001.

Supplementary Figure 2 Knockdown of Syk or Mapk8-Mapk9 in primary macrophages.

(a,b,e,f) Immunoblot analysis of caspase-1 or (c,d) enzyme-linked immunosorbent assayof IL-18 in peritoneal macrophages unprimed (a,b), primed with LPS for 4 h, followed by stimulation with nigericin for 90 min (c,e), or unprimed macrophages stimulated with poly(dA:dT) for 3 h (d,f). Macrophages were transfected with siRNAs for 48 h. Control, negative control siRNA; CL, cell lysates; SN, supernatants; ND, not detected. Data are shown as the means ± s.d. of triplicate samples of one experiment representative of three independent experiments. Data were analyzed by one-way ANOVA with Bonferroni multiple comparison test (c,d). * P < 0.001.

Supplementary Figure 3 Syk is not required for NLRP3 inflammasome activation in dendritic cells.

(a,b) Enzyme-linked immunosorbent assayof IL-18 or (c,d) immunoblot analysis of inflammasome molecules in bone marrow–derived dendritic cells(a,c,d) or bone marrow–derived macrophages(b,e) primed with LPS for 4 h, followed by stimulation with nigericin for 90 min. Bone marrow–derived macrophageswere prepared using L-cell conditioned medium. CL, cell lysates; SN, supernatants. Data are shown as the means ± s.d. of triplicate samples of one experiment representative of two independent experiments. Data were analyzed by two-tailed unpaired t test with Welch's correction (a,b). * P < 0.01.

Supplementary Figure 4 Implication that Syk contributes to inflammasome activity through an unknown mechanism.

(a–g) Immunoblot analysis of kinases, (h–j) enzyme-linked immunosorbent assayof IL-18, or (k) FACS analysis of mitochondrial ROS in peritoneal macrophages primed with LPS for 4 h, followed by stimulation with nigericin for the indicated times (a,c,e,g,h,j,k), or unprimed macrophages stimulated with poly(dA:dT) for 3 h (b,d,f,i,j). The kinase inhibitors and BHA (25 mM) were added to the cultures 1 h before stimulation (a–e,j,k). The cells were incubated with nigericin for 20 min in the presence of MitoSOX (5 mM) and analyzed on a flow cytometer (k). Data are shown as the means ± s.d. of triplicate samples of one experiment. Data shown in e,f,h–k are representative of three independent experiments and those in a–d,g are representative of two independent experiments. Data were analyzed by two-tailed unpaired t test with Welch's correction (h–j). * P < 0.001.

Supplementary Figure 5 Requirement of Syk and Jnk for ASC speck formation induced by poly(dA:dT).

(a–d) ASC staining or (e,f) immunoblot analysis of ASC in peritoneal macrophages primed with LPS for 4 h, followed by stimulation with nigericin for 90 min (a,b), or unprimed macrophages stimulated with poly(dA:dT) for the indicated times (c–f). The kinase inhibitors were added to the cultures 1 h before stimulation (c–f). ASC is shown in green, nuclei in blue (a–c). The number of ASC speck-positive cell was counted and normalized to that of dimethyl sulfoxide(d). Triton-soluble (S) and Triton-insoluble (I) fractions (right margin; e) or Triton-insoluble fractions treated with DSS (I + DSS; f).Data are shown as the means ± s.d. of triplicate samples of one experiment. Data shown in c–f are representative of three independent experiments and those in a,b are representative of two independent experiments. Data were analyzed by Kruskal-Wallis test with Dunn's multiple comparison test (d). Scale bar, 10 mm. * P < 0.05.

Supplementary Figure 6 Prediction of phosphorylation sites in mouse ASC.

Possible phosphorylation sites in the amino acid sequence of mouse ASC were predicted by using the online program NetPhos 2.0. The threshold is 0.5.

Supplementary Figure 7 Reconstitution of inflammasome system in HEK293 cells.

(a, b) Immunoblot analysis of inflammasome molecules in reconstituted HEK293 cells transfected as described in Fig. 5a,b.

Supplementary Figure 8 Involvement of ASC and Jnk in inflammatory responses to MSU and Alum in vivo.

(a–f) Infiltration of inflammatory cells in the peritoneal cavity induced by intraperitoneal injection of MSU (a–c) or alum (d–f) at 6 h after injection. Two hours before and 30 min later administration of the irritants, the mice were intraperitoneally treated with Jnk inhibitor. (g–l) Infiltration of inflammatory cells in the peritoneal cavity induced by intraperitoneal injection of KC or PBS at 1.5 h after injection. Absolute numbers of PECs (a,d,g,j), Gr-1+ F4/80– neutrophils (b,e,h,k), and F4/80+ monocytes and macrophages (c,f,i,l) in the peritoneum were then determined. Data are shown as dots, and the bars indicate the means ± s.d. (n = 7 for a–f; n = 5 for g–l; n = 3 for PBS control in g–l). Data were analyzed by one-way ANOVA with Bonferroni (a–d,f) or Tukey-Kramer (g–l) multiple comparison test, or Kruskal-Wallis test with Dunn's multiple comparison test (e). NS, no significant difference. * P < 0.05 , ** P < 0.01 and *** P< 0.001.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–8 and Supplementary Tables 1–3 (PDF 972 kb)

Source data

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hara, H., Tsuchiya, K., Kawamura, I. et al. Phosphorylation of the adaptor ASC acts as a molecular switch that controls the formation of speck-like aggregates and inflammasome activity. Nat Immunol 14, 1247–1255 (2013). https://doi.org/10.1038/ni.2749

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ni.2749

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing